Search Results 831-840 of 23943 for B cell lymphomas
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
CAR-T cell therapy is a personalized and innovative treatment giving hope to patients diagnosed with various lymphomas. Learn more.
... B-precursor Acute Lymphoblastic Leukemia (ALL). ... cell tumors (NGGCT) treated with Induction ... lymphoma (DLBCL) patients with out of specification ...
... B) in patients with previously treated mantle cell lymphoma (MCL). Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
DEAR MAYO CLINIC: My father just started chemotherapy for lymphoma, and he is scheduled for a positron emission tomography or PET scan after his first three ...
Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato ...
... B-Cell Lymphoma featured image. Cancer. Everolimus R-CHOP Combination Safe for Treating Diffuse Large B-Cell Lymphoma. Joe Dangor. June 29, 2016. First ...
... B-cell Lymphoma. Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville ... B-cell lymphoma with respect to PFS as assessed by the investigator.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!